pd 98059 has been researched along with Colitis Gravis in 2 studies
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sugihara, T | 1 |
| Kobori, A | 1 |
| Imaeda, H | 1 |
| Tsujikawa, T | 1 |
| Amagase, K | 1 |
| Takeuchi, K | 1 |
| Fujiyama, Y | 1 |
| Andoh, A | 1 |
| Nishise, S | 1 |
| Takeda, Y | 1 |
| Fujishima, S | 1 |
| Orii, T | 1 |
| Sato, T | 1 |
| Sasaki, Y | 1 |
| Nishise, Y | 1 |
| Takeda, H | 1 |
| Kawata, S | 1 |
2 other studies available for pd 98059 and Colitis Gravis
| Article | Year |
|---|---|
The increased mucosal mRNA expressions of complement C3 and interleukin-17 in inflammatory bowel disease.
Topics: Adenoviridae; Colitis, Ulcerative; Colon; Complement C3; Crohn Disease; Dose-Response Relationship, | 2010 |
Release of interleukin-1 receptor antagonist by combining a leukocyte adsorption carrier with ulinastatin.
Topics: Adsorption; Blood Component Removal; Cellulose; Colitis, Ulcerative; Dose-Response Relationship, Dru | 2010 |